How big is the Glioblastoma Multiforme Treatment Market?

The Glioblastoma Multiforme Treatment Market size is expected to reach USD 2.80 billion in 2024 and grow at a CAGR of 8% to reach USD 4.60 billion by 2029. Read More

What is the current Glioblastoma Multiforme Treatment Market size?

In 2024, the Glioblastoma Multiforme Treatment Market size is expected to reach USD 2.80 billion. Read More

Who are the key players in Glioblastoma Multiforme Treatment Market?

Arbor Pharmaceuticals, LLC, F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Sun Pharmaceutical Industries Ltd. and Teva Pharmaceutical Industries Ltd. are the major companies operating in the Glioblastoma Multiforme Treatment Market. Read More

Which is the fastest growing region in Glioblastoma Multiforme Treatment Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Glioblastoma Multiforme Treatment Market?

In 2024, the North America accounts for the largest market share in Glioblastoma Multiforme Treatment Market. Read More

What years does this Glioblastoma Multiforme Treatment Market cover, and what was the market size in 2023?

In 2023, the Glioblastoma Multiforme Treatment Market size was estimated at USD 2.58 billion. The report covers the Glioblastoma Multiforme Treatment Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Glioblastoma Multiforme Treatment Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Glioblastoma Multiforme Treatment Market Share

Statistics for the 2023 & 2024 Glioblastoma Multiforme Treatment market share, created by Mordor Intelligence™ Industry Reports. Glioblastoma Multiforme Treatment share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Glioblastoma Multiforme Treatment Industry

The glioblastoma multiforme treatment market is moderately concentrated in nature due to the presence of companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies that hold market shares and are well known, including Arbor Pharmaceuticals, Bristol-Myers Squibb, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Sun Pharmaceuticals, and Teva Pharmaceutical Industries Ltd.